Table 1 Patient Characteristics (n = 69)
Characteristics | Value |
|---|---|
Age (years) | |
 Median | 68 |
 Range | 41–79 |
Sex, n | |
 Male | 53 |
 Female | 16 |
Smoking status, n | |
 Current or Former smoker | 59 |
 Never smoked | 10 |
Histological type, n | |
 Adenocarcinoma | 39 |
 squamous cell carcinoma | 25 |
 others | 5 |
Disease stage, n | |
 IIIB | 11 |
 IV | 58 |
Driver mutation status, n | |
 EGFR mutation | 8 |
 ALK translocation | 1 |
 negative or unknown | 60 |
No. of prior systemic regimens, n | |
 1 | 61 |
  > 2 | 8 |
Prior platinum drug therapy, n | |
 Yes | 64 |
 No | 5 |
No. of docetaxel cycles | |
 Median | 2 |
 Range | 1–14 |
Overall response for docetaxel | |
 Complete Response | 0 |
 Partial Response | 6 |
 Stable Disease | 23 |
 Progressive Disease | 33 |
 Not Evaluable | 7 |
Neutropenia in first cycle of docetaxel | |
 Grade 0 | 3 |
 Grade 1 | 5 |
 Grade 2 | 5 |
 Grade 3 | 17 |
 Grade 4 | 39 |
 Grade 5 | 0 |